Federal inspectors found the facility failed to obtain laboratory tests as ordered for Resident 10, who returned from the hospital on April 5 with orders for intravenous Vancomycin every 12 hours and blood level checks every Monday.
The resident began receiving the antibiotic at 8:00 p.m. on April 6. But the facility didn't draw blood to check Vancomycin levels until April 14 — eight days later.
Pharmacist 165 told inspectors during an October 30 interview that Vancomycin levels should be drawn before the fourth dose for safe dosing. The resident would have received their fourth dose by April 8, two days after starting the medication.
The pharmacy had sent recommendations to the facility indicating the need to obtain pre-dose Vancomycin levels. The facility ignored those recommendations.
Resident 10's medical record showed an admission date of June 28, 2024, with diagnoses including infection and inflammation of internal right hip prosthesis, chronic obstructive pulmonary disease, alcoholic cirrhosis of liver with ascites, and hypertension. The resident had been discharged to the hospital and returned on April 5.
Hospital discharge orders were clear: administer Vancomycin one gram every 12 hours intravenously, and obtain Vancomycin levels every Monday.
The medication administration record confirmed the resident received their first dose at 8:00 p.m. on April 6. But lab results showed no Vancomycin level was drawn until April 14.
During the October 30 inspection, the facility administrator confirmed the timeline. The administrator acknowledged Resident 10 had orders for Vancomycin every 12 hours and for weekly blood level monitoring. The administrator further confirmed the facility began giving the antibiotic on April 6 at 8:00 p.m. but didn't obtain the required blood work until April 14.
Vancomycin is a potent antibiotic used to treat serious bacterial infections. Blood level monitoring is critical because the drug can cause kidney damage and hearing loss if levels become too high, or treatment failure if levels are too low.
The pharmacy's recommendation for pre-dose level monitoring reflects standard medical practice. These levels help determine whether the dosing is appropriate for each patient's kidney function and infection severity.
By waiting eight days to check blood levels, the facility administered at least 16 doses of Vancomycin without knowing if the resident was receiving a safe or effective amount. The resident received doses on April 6, 7, 8, 9, 10, 11, 12, 13, and 14 before the first blood draw.
The violation affected one resident out of three reviewed during the complaint investigation. The facility's census was 65 residents.
Federal inspectors classified the violation as minimal harm or potential for actual harm affecting few residents. The deficiency represents noncompliance investigated under complaint number 1263206.
The inspection was conducted on October 30 in response to a complaint. Inspectors reviewed medical records and interviewed staff, including the pharmacist and administrator.
The facility's failure to follow laboratory monitoring orders violated federal regulations requiring nursing homes to provide or obtain laboratory tests when ordered and promptly tell the ordering practitioner of results.
Hospital discharge orders serve as the physician's instructions for continuing care. When facilities ignore these orders, they put residents at risk and undermine the continuity of care between hospital and nursing home settings.
The eight-day delay in monitoring meant the facility had no way to know if Resident 10 was receiving appropriate antibiotic therapy during a critical period following hospitalization for infection.
Full Inspection Report
The details above represent a summary of key findings. View the complete inspection report for Aventura At Carriage Inn from 2025-10-30 including all violations, facility responses, and corrective action plans.